Compound Summary
Compound Information
glutathione
Compound Name: | glutathione |
Compound CID: | 124886 |
Synonyms: | glutathione 70-18-8 L-Glutathione Glutathion Isethion More... |
Iupac Name: | (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid |
InChI: | InChI=1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/t5-,6-/m0/s1 |
InChIKey: | RWSXRVCMGQZWBV-WDSKDSINSA-N |
Canonical Smiles: | C(CC(=O)NC(CS)C(=O)NCC(=O)O)C(C(=O)O)N |
Isomeric Smiles: | C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C(=O)O)N |
Molecular Weight: | 307.33 |
Molecular Formula: | C10H17N3O6S |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
glutathione
Molecular Weight: | 307.33 |
Molecular Formula: | C10H17N3O6S |
Hydrogen Bond Donor Count: | 6 |
Hydrogen Bond Acceptor Count: | 8 |
Rotatable Bond Count: | 9 |
Heavy Atom Count: | 20 |
Complexity: | 389 |
Synonyms
glutathione
| glutathione | glutathione |
|---|---|
glutathione |
70-18-8 |
L-Glutathione |
Glutathion |
Isethion |
Tathion |
L-Glutathione reduced |
reduced glutathione |
Glutathione-SH |
Glutinal |
Deltathione |
Neuthion |
Copren |
Glutide |
Tathione |
Triptide |
Ledac |
GSH |
Glutatione |
Glutatiol |
Glutathione (reduced) |
glutathione reduced |
Panaron |
L-gamma-glutamyl-L-cysteinylglycine |
Glutathione SH |
L-Glutatione |
Agifutol S |
gamma-L-Glutamyl-L-cysteinylglycine |
L-Glutathione, reduced |
gamma-L-glutamyl-L-cysteinyl-glycine |
5-L-Glutamyl-L-cysteinylglycine |
gamma-L-Glutamylcysteinylglycine |
glutathione red |
red. glutathione |
Bakezyme RX |
UNII-GAN16C9B8O |
L-Glutathione reduce |
Glycine, L-gamma-glutamyl-L-cysteinyl- |
(2S)-2-amino-5-(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-ylamino-5-oxopentanoic acid |
N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine |
N-(N-L-gamma-Glutamyl-L-cysteinyl)glycine |
glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)- |
(S)-2-Amino-5-(((R)-1-((carboxymethyl)amino)-3-mercapto-1-oxopropan-2-yl)amino)-5-oxopentanoic acid |
GAN16C9B8O |
L-glutamyl-L-cysteinylglycine |
L-Glutathione (reduced form) |
Glycine, L-.gamma.-glutamyl-L-cysteinyl- |
(2S)-2-amino-4-{(1R)-1-(carboxymethyl)carbamoyl-2-sulfanylethylcarbamoyl}butanoic acid |
BenzenaMine, 2-(4-Methoxyphenyl)Methoxy- |
CHEBI:16856 |
106272-20-2 |
DSSTox_CID_3101 |
N5-((R)-1-((carboxymethyl)amino)-3-mercapto-1-oxopropan-2-yl)-L-glutamine |
DSSTox_RID_76875 |
DSSTox_GSID_23101 |
gamma-Glutamylcysteinylglycine |
Glu(-Cys)n-Gly |
95687-20-0 |
Glutathione JAN |
MFCD00065939 |
CAS-70-18-8 |
(S)-2-Amino-5-((R)-1-(carboxymethylamino)-3-mercapto-1-oxopropan-2-ylamino)-5-oxopentanoic acid |
CCRIS 2094 |
Glycine, N-(N-L-.gamma.-glutamyl-L-cysteinyl)- |
SR-05000002567 |
Glutathione BAN:JAN |
EINECS 200-725-4 |
L-Glutathione reduced form |
NSC 400639 |
phytochelatins |
ReadiSorb |
Glutathione; |
NSC400639 |
1lbk |
NCGC00094976-01 |
Tathion (TN) |
Glutathione (JP17) |
Spectrum_000419 |
1oe7 |
1oe8 |
1r4w |
C(N-.gamma.Glu-)G |
Reduced Glutathione,(S) |
Spectrum2_001500 |
Spectrum3_000946 |
Spectrum4_001056 |
Spectrum5_000940 |
Glutathione, Reduced Form |
bmse000185 |
bmse000952 |
bmse000956 |
Glutathione (Reduced type) |
Cys(N-.gamma.Glu-)-Gly |
SCHEMBL9167 |
CHEMBL1543 |
KBioGR_001352 |
KBioSS_000899 |
MLS001333069 |
DivK1c_000075 |
SPECTRUM1502248 |
SPBio_001519 |
gamma-glutamyl-cysteinyl-glycine |
GTPL6737 |
DTXSID6023101 |
L-?-glutamyl-L-cysteinylglycine |
L-Glutathione reduced, 97.0% |
CHEBI:60836 |
HMS500D17 |
KBio1_000075 |
KBio2_000899 |
KBio2_003467 |
KBio2_006035 |
KBio3_002012 |
(gamma-Glutamylcysteine)n-glycine |
L-g-glutamyl-L-cysteinyl-glycine |
y-L-Glutamyl-L-cysteinyl-glycine |
L-?-glutamyl-L-cysteinyl-glycine |
L-??-glutamyl-L-cysteinylglycine |
NINDS_000075 |
HMS1921N22 |
Pharmakon1600-01502248 |
Poly(gamma-glutamylcysteine)glycine |
HY-D0187 |
L-Glutathione reduced, >=98.0% |
ZINC3830891 |
gam.-L-Glutamyl-L-cysteinyl-glycine |
Tox21_111371 |
BDBM50422268 |
CCG-38876 |
L-gamma-glutamyl-L-cysteinyl-glycine |
NSC758199 |
s4606 |
AKOS015999135 |
Tox21_111371_1 |
CS-7948 |
DB00143 |
MCULE-3371744018 |
NSC-758199 |
SDCCGMLS-0066687.P001 |
.gamma.-L-Glutamyl-L-cysteinyl-glycine |
IDI1_000075 |
N-(N-L-?-Glutamyl-L-cysteinyl)glycine |
Pharm Biol 11: 539 (1968) |
SMP1_000247 |
NCGC00264046-02 |
DS-14675 |
SMR000857220 |
ST097777 |
SBI-0051743.P002 |
L-Glutathione reduced, BioXtra, >=98.0% |
B7775 |
G0074 |
Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl) |
N-(N-L-.gamma.-Glutamyl-L-cysteinyl)glycine |
C00051 |
C02471 |
D00014 |
G-3980 |
P19615 |
AB00443568_03 |
Glutathione 100 microg/mL in Acetonitrile:Water |
Glycine, N-(N-L- gamma-glutamyl-L-cysteinyl)- |
A866658 |
Q116907 |
SR-05000002567-1 |
SR-05000002567-2 |
L-Glutathione reduced, Vetec(TM) reagent grade, >=98% |
Z2183947556 |
Glutathione, European Pharmacopoeia (EP) Reference Standard |
Glutathione, United States Pharmacopeia (USP) Reference Standard |
Glutathione, Pharmaceutical Secondary Standard; Certified Reference Material |
L-Glutathione reduced, cell culture tested, BioReagent, >=98.0%, powder |
(2S)-2-AMINO-4-{(1R)-1-(CARBOXYMETHYL)CARBAMOYL-2-SULFANYLETHYLCARBAMOYLBUTANOIC ACID |
(2S)-2-Amino-5-({(2R)-1-(carboxymethyl)amino-1-oxo-3-sulfanyl-2-propanyl}amino)-5-oxopentanoic acid |
4-(N-{(1R)-1-N-(carboxymethyl)carbamoyl-2-sulfanylethyl}carbamoyl)(2S)-2-ami nobutanoic acid |
Experimental Data
glutathione
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 5 | umol/L | -13.9 | S | N2 | 34267196 | Inactive |
Experimental Data Visualization
glutathione
Statistics Data
glutathione
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -13.9 | 1 | 1 |
Statistics Data Visualization
glutathione
